FC 336

Known as: FC-336 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2006
012319982006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
We have shown that the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) inhibits… (More)
Is this relevant?
2004
2004
BACKGROUND Port-site metastasis is a continuing problem in laparoscopic cancer surgery. To clarify the role of adhesion molecules… (More)
Is this relevant?
2003
2003
Port-site metastasis is a continuing problem in laparoscopic cancer surgery. To clarify the role of adhesion molecules in the… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2002
2002
We have previously reported that the expression of matrix metalloproteinase-9 (MMP-9), membrane type-1 matrix metalloproteinase… (More)
Is this relevant?
1998
1998
A series of pseudo-peptide analogs of the Arg-Gly-Asp (RGD) sequence of fibronectin have been synthe-sized, and their anti… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
1998
1998
Tumor invasion into the extracellular matrix (ECM) and basement membrane (BM) is a crucial step of tumor metastasis. In order to… (More)
Is this relevant?
1998
1998
We have investigated the effect of the pseudo-peptide analogue (FC-336) of the Arg-Gly-Asp (RGD) sequence in a liver metastasis… (More)
Is this relevant?